Lung cancer detection in perioperative patients' exhaled breath with nanomechanical sensor array

The number of lung cancer deaths is the highest among all cancer types worldwide [1]. The 5-year survival rate of lung cancer decreases with the advance of the stage, from stage IA1 (92  %) to stage IVB (0 %), according to an IASLC report [2]. Therefore, it is essential to detect and treat lung cancer at an early stage. However, lung cancer is difficult to detect in its early stages because it often remains asymptomatic until more advanced stages. Although screening through low -dose computed tomography (CT) has been reported to reduce the lung cancer mortality rate, CT screening is expensive, labor intensive, and the rate of false positives is relatively high, 56–96 % [3–5].

Source: Lung Cancer - February 25, 2024 Category: Cancer & Oncology Authors: Yusuke Saeki, Naoki Maki, Takahiro Nemoto, Katsushige Inada, Kosuke Minami, Ryo Tamura, Gaku Imamura, Yukiko Cho-Isoda, Shinsuke Kitazawa, Hiroshi Kojima, Genki Yoshikawa, Yukio Sato Source Type: research